Latest Insider Transactions at Day One Biopharmaceuticals, Inc. (DAWN)
This section provides a real-time view of insider transactions for Day One Biopharmaceuticals, Inc. (DAWN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Day One Biopharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Day One Biopharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 19
2023
|
Ai Day1 LLC |
BUY
Open market or private purchase
|
Direct |
384,400
+2.91%
|
$3,844,000
$10.06 P/Share
|
|
Oct 18
2023
|
Ai Day1 LLC |
BUY
Open market or private purchase
|
Direct |
979,667
+7.3%
|
$9,796,670
$10.21 P/Share
|
|
Aug 17
2023
|
Charles N York Ii COO, CFO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
922
-0.34%
|
$11,986
$13.86 P/Share
|
|
Aug 17
2023
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
668
-0.05%
|
$8,684
$13.86 P/Share
|
|
Aug 17
2023
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
2,996
-0.42%
|
$38,948
$13.86 P/Share
|
|
Aug 15
2023
|
Charles N York Ii COO, CFO AND SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
3,625
+0.67%
|
-
|
|
Aug 15
2023
|
Samuel C. Blackman HEAD OF R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
2,624
+0.11%
|
-
|
|
Aug 15
2023
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,312
+0.59%
|
-
|
|
Jul 01
2023
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
BUY
Bona fide gift
|
Indirect |
570,251
+31.64%
|
-
|
|
Jul 01
2023
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Bona fide gift
|
Indirect |
329,963
-43.95%
|
-
|
|
Jul 01
2023
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Bona fide gift
|
Direct |
240,288
-25.58%
|
-
|
|
Jul 01
2023
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
BUY
Other acquisition or disposition
|
Indirect |
240,288
+50.0%
|
-
|
|
Jul 01
2023
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Other acquisition or disposition
|
Direct |
240,288
-20.37%
|
-
|
|
Jun 09
2023
|
Ai Day1 LLC |
BUY
Open market or private purchase
|
Direct |
769,230
+6.29%
|
$9,999,990
$13.0 P/Share
|
|
Jun 05
2023
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
1,229
-0.1%
|
$19,664
$16.0 P/Share
|
|
May 16
2023
|
Charles N York Ii COO, CFO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
955
-0.36%
|
$12,415
$13.12 P/Share
|
|
May 16
2023
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
692
-0.06%
|
$8,996
$13.12 P/Share
|
|
May 16
2023
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
3,104
-0.26%
|
$40,352
$13.12 P/Share
|
|
May 15
2023
|
Charles N York Ii COO, CFO AND SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
3,625
+0.68%
|
-
|
|
May 15
2023
|
Samuel C. Blackman HEAD OF R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
2,624
+0.11%
|
-
|
|
May 15
2023
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,312
+0.35%
|
-
|
|
Mar 10
2023
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
10,000
-0.8%
|
$180,000
$18.05 P/Share
|
|
Mar 07
2023
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
12,500
-1.05%
|
$250,000
$20.01 P/Share
|
|
Mar 01
2023
|
Papanek Julie Grant Director |
SELL
Open market or private sale
|
Indirect |
25,000
-7.04%
|
$450,000
$18.61 P/Share
|
|
Feb 17
2023
|
Charles N York Ii COO, CFO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
9,377
-3.45%
|
$187,540
$20.03 P/Share
|
|
Feb 16
2023
|
Charles N York Ii COO, CFO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
930
-0.34%
|
$17,670
$19.57 P/Share
|
|
Feb 16
2023
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
674
-0.05%
|
$12,806
$19.57 P/Share
|
|
Feb 16
2023
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
3,022
-0.25%
|
$57,418
$19.57 P/Share
|
|
Feb 15
2023
|
Charles N York Ii COO, CFO AND SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
3,625
+0.66%
|
-
|
|
Feb 15
2023
|
Samuel C. Blackman HEAD OF R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
2,624
+0.11%
|
-
|
|
Feb 15
2023
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,312
+0.35%
|
-
|
|
Feb 10
2023
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
10,000
-0.8%
|
$200,000
$20.07 P/Share
|
|
Feb 01
2023
|
Papanek Julie Grant Director |
SELL
Open market or private sale
|
Indirect |
25,000
-3.3%
|
$525,000
$21.45 P/Share
|
|
Jan 23
2023
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
12,500
-1.05%
|
$275,000
$22.0 P/Share
|
|
Jan 20
2023
|
Charles N York Ii COO, CFO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
10,000
-3.59%
|
$220,000
$22.75 P/Share
|
|
Jan 10
2023
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
10,000
-0.4%
|
$220,000
$22.98 P/Share
|
|
Jan 03
2023
|
Papanek Julie Grant Director |
SELL
Open market or private sale
|
Indirect |
25,000
-3.13%
|
$500,000
$20.84 P/Share
|
|
Dec 21
2022
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
12,500
-1.04%
|
$250,000
$20.32 P/Share
|
|
Dec 20
2022
|
Charles N York Ii COO, CFO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
10,000
-3.49%
|
$200,000
$20.07 P/Share
|
|
Dec 12
2022
|
Atlas Venture Fund Xi, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
600,854
-9.09%
|
-
|
|
Dec 08
2022
|
Papanek Julie Grant Director |
SELL
Open market or private sale
|
Indirect |
4,358
-1.06%
|
$95,876
$22.08 P/Share
|
|
Dec 02
2022
|
Papanek Julie Grant Director |
SELL
Open market or private sale
|
Indirect |
5,000
-1.21%
|
$105,000
$21.55 P/Share
|
|
Dec 01
2022
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
10,000
-0.39%
|
$210,000
$21.77 P/Share
|
|
Dec 01
2022
|
Papanek Julie Grant Director |
SELL
Open market or private sale
|
Indirect |
5,000
-0.6%
|
$110,000
$22.03 P/Share
|
|
Nov 21
2022
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
12,500
-0.51%
|
$262,500
$21.06 P/Share
|
|
Nov 21
2022
|
Charles N York Ii COO, CFO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
10,000
-1.69%
|
$210,000
$21.07 P/Share
|
|
Nov 16
2022
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
1,513
-0.12%
|
$31,773
$21.46 P/Share
|
|
Nov 16
2022
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
377
-0.03%
|
$7,917
$21.46 P/Share
|
|
Nov 16
2022
|
Charles N York Ii COO, CFO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
430
-0.14%
|
$9,030
$21.46 P/Share
|
|
Nov 15
2022
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,562
+0.29%
|
-
|